MARATTO

article · Neurology

The Safety and Efficacy of Subcutaneous Forms of Levodopa/Carbidopa (ND0612 and Foslevodopa/Foscarbidopa) on Parkinson’s Disease Patients: Systematic Review and Meta Analysis (P11-5.030)

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The safety and efficacy of subcutaneous forms of levodopa/carbidopa.

Research topics

  • Parkinson's Disease Mechanisms and Treatments

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1212/wnl.0000000000212037

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.